The biological function of BAFF and APRIL is not limited to B cell malignancy but extends to autoimmune disorders and other diseases triggered by pathological B cells, suggesting a much broader clinical indication for sBCMA-Fc V3 (Samy et al., 2017). The gene discussed is TNFSF13B; the disease is autoimmune disease.